Pharmacists' Medication Reconciliation Interventions During Admission and Transfer from an Emergency Department at a Tertiary Care Hospital: A Randomized Pilot Study and Evaluation of Physician and Patient Perceptions.

IF 1.1 Q4 PHARMACOLOGY & PHARMACY
Ashitha George Joseph, Santra Saji, Anagha Nivrutti Kumbhar, G Shivakumar, Ramesh Bhandari, M S Ganachari
{"title":"Pharmacists' Medication Reconciliation Interventions During Admission and Transfer from an Emergency Department at a Tertiary Care Hospital: A Randomized Pilot Study and Evaluation of Physician and Patient Perceptions.","authors":"Ashitha George Joseph, Santra Saji, Anagha Nivrutti Kumbhar, G Shivakumar, Ramesh Bhandari, M S Ganachari","doi":"10.2174/1574886318666230911144912","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>The study aimed to assess the impact of pharmacist interventions during the transition of care.</p><p><strong>Background: </strong>Medication discrepancies can occur at various levels of transition, such as during admission, the transition from emergency to special wards or from special to general wards, and during discharge. Discrepancies can be detected through the process of medication reconciliation.</p><p><strong>Objective: </strong>The objective of the study was to compare discrepancies among patients exposed to pharmacist intervention groups and those who were not and assess the perception of healthcare professionals and patients towards integrating pharmacists in the transition care process.</p><p><strong>Methods: </strong>A pharmacist-led interventional study was conducted for six months on patients above 18 years of age and either sex who were admitted to the emergency department, had chronic diseases, and subsequently transferred to another department (any). The patients were randomized into intervention and control groups. The pharmacist performed a medication reconciliation and medication review to identify discrepancies in every transition in both the groups, and then reported to the treating physician to resolve in the intervention group.</p><p><strong>Results: </strong>Among the 73 patients recruited in the study, 152 discrepancies were identified. The total discrepancies observed in the control and intervention groups were 78 (51.3%) and 74 (48.6%), respectively. The majority, 35.53%, were found during the transition from emergency to special wards. The physician, upon pharmacist recommendations, accepted and resolved 48 discrepancies in the intervention group. The healthcare professional acceptance rate of pharmacist interventions was 64.86%.</p><p><strong>Conclusion: </strong>The transitions of care are at risk for errors due to medication discrepancies, and pharmacists could potentially identify and resolve discrepancies. Healthcare professionals and patients reported to be satisfied by the involvement of clinical pharmacists in the healthcare team.</p>","PeriodicalId":10777,"journal":{"name":"Current drug safety","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug safety","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574886318666230911144912","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: The study aimed to assess the impact of pharmacist interventions during the transition of care.

Background: Medication discrepancies can occur at various levels of transition, such as during admission, the transition from emergency to special wards or from special to general wards, and during discharge. Discrepancies can be detected through the process of medication reconciliation.

Objective: The objective of the study was to compare discrepancies among patients exposed to pharmacist intervention groups and those who were not and assess the perception of healthcare professionals and patients towards integrating pharmacists in the transition care process.

Methods: A pharmacist-led interventional study was conducted for six months on patients above 18 years of age and either sex who were admitted to the emergency department, had chronic diseases, and subsequently transferred to another department (any). The patients were randomized into intervention and control groups. The pharmacist performed a medication reconciliation and medication review to identify discrepancies in every transition in both the groups, and then reported to the treating physician to resolve in the intervention group.

Results: Among the 73 patients recruited in the study, 152 discrepancies were identified. The total discrepancies observed in the control and intervention groups were 78 (51.3%) and 74 (48.6%), respectively. The majority, 35.53%, were found during the transition from emergency to special wards. The physician, upon pharmacist recommendations, accepted and resolved 48 discrepancies in the intervention group. The healthcare professional acceptance rate of pharmacist interventions was 64.86%.

Conclusion: The transitions of care are at risk for errors due to medication discrepancies, and pharmacists could potentially identify and resolve discrepancies. Healthcare professionals and patients reported to be satisfied by the involvement of clinical pharmacists in the healthcare team.

药剂师在一家三甲医院急诊科入院和转院期间的用药调和干预:一项随机试点研究以及对医生和患者看法的评估。
目的:本研究旨在评估药剂师干预对护理过渡的影响:背景:在入院、从急诊病房转入特殊病房或从特殊病房转入普通病房以及出院等不同过渡阶段都可能出现用药差异。差异可通过药物调节过程发现:本研究旨在比较接受药剂师干预组和未接受药剂师干预组患者之间的差异,并评估医护人员和患者对将药剂师纳入过渡护理流程的看法:以药剂师为主导,对急诊科收治的 18 岁以上、患有慢性病并随后转入其他科室(任一科室)的男女患者进行了为期 6 个月的干预研究。患者被随机分为干预组和对照组。药剂师在干预组和对照组的每次转科过程中都会进行药物对账和药物审查,以发现差异,然后报告给主治医生解决:结果:在参与研究的 73 名患者中,共发现 152 处差异。对照组和干预组观察到的差异总数分别为 78 个(51.3%)和 74 个(48.6%)。其中大部分(35.53%)是在从急诊病房转入特殊病房的过程中发现的。在干预组中,医生根据药剂师的建议接受并解决了 48 例差异。医护人员对药剂师干预的接受率为 64.86%:结论:由于用药差异,护理过渡过程中存在出错的风险,而药剂师有可能识别并解决差异问题。医护人员和患者对临床药剂师参与医护团队表示满意。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current drug safety
Current drug safety PHARMACOLOGY & PHARMACY-
CiteScore
2.10
自引率
0.00%
发文量
112
期刊介绍: Current Drug Safety publishes frontier articles on all the latest advances on drug safety. The journal aims to publish the highest quality research articles, reviews and case reports in the field. Topics covered include: adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, post-marketing surveillance. The journal is essential reading for all researchers and clinicians involved in drug safety.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信